Peter Dall

4.7k total citations
97 papers, 2.5k citations indexed

About

Peter Dall is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Peter Dall has authored 97 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Molecular Biology and 25 papers in Genetics. Recurrent topics in Peter Dall's work include Aquatic Invertebrate Ecology and Behavior (19 papers), Virus-based gene therapy research (17 papers) and Proteoglycans and glycosaminoglycans research (12 papers). Peter Dall is often cited by papers focused on Aquatic Invertebrate Ecology and Behavior (19 papers), Virus-based gene therapy research (17 papers) and Proteoglycans and glycosaminoglycans research (12 papers). Peter Dall collaborates with scholars based in Germany, United States and Denmark. Peter Dall's co-authors include Claus Lindegaard, Helmut Ponta, Peter Herrlich, Kirsten Hamburger, David T. Curiel, Armin Hekele, S. Djahansouzi, Karl‐Heinz Heider, Mariam A. Stoff‐Khalili and Hans Bender and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Peter Dall

89 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Dall Germany 30 1.1k 805 752 401 386 97 2.5k
Noriyuki Takai Japan 32 1.6k 1.5× 765 1.0× 267 0.4× 535 1.3× 384 1.0× 130 3.5k
Lorraine Robb Australia 39 3.5k 3.2× 1.2k 1.5× 717 1.0× 374 0.9× 269 0.7× 52 6.4k
Luc Bélanger Canada 35 1.1k 1.1× 397 0.5× 708 0.9× 675 1.7× 103 0.3× 101 3.2k
Riccardo Giannini Italy 34 1.6k 1.5× 1.4k 1.8× 699 0.9× 83 0.2× 130 0.3× 104 4.6k
R Swain Australia 19 716 0.7× 653 0.8× 137 0.2× 337 0.8× 237 0.6× 79 2.0k
Jun Yamamoto Japan 30 590 0.5× 345 0.4× 403 0.5× 225 0.6× 71 0.2× 171 2.7k
Rainer Lehtonen Finland 26 907 0.8× 386 0.5× 364 0.5× 84 0.2× 99 0.3× 69 2.3k
Daniel Auclair United States 31 1.6k 1.4× 807 1.0× 130 0.2× 112 0.3× 167 0.4× 137 3.5k
Mercedes Herrera Spain 24 1.2k 1.1× 737 0.9× 118 0.2× 90 0.2× 102 0.3× 47 2.5k
Donald R. Howard United States 28 524 0.5× 409 0.5× 184 0.2× 78 0.2× 163 0.4× 64 2.3k

Countries citing papers authored by Peter Dall

Since Specialization
Citations

This map shows the geographic impact of Peter Dall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dall more than expected).

Fields of papers citing papers by Peter Dall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Dall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dall. The network helps show where Peter Dall may publish in the future.

Co-authorship network of co-authors of Peter Dall

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Dall. A scholar is included among the top collaborators of Peter Dall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Dall. Peter Dall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dall, Peter, et al.. (2020). Feasibility of internal inguinoperitoneal drainage after inguinofemoral lymphadenectomy in vulvar cancer. Archives of Gynecology and Obstetrics. 301(6). 1513–1519.
2.
3.
Dall, Peter, Thomas Göhler, Christian Lerchenmüller, et al.. (2015). Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany. Journal of Geriatric Oncology. 6(6). 462–469. 19 indexed citations
4.
Emons, G., Philipp Harter, Pauline Wimberger, et al.. (2014). Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors. International Journal of Gynecological Cancer. 24(2). 260–265. 47 indexed citations
5.
Dall, Peter, Cornelia Liedtke, Brigitte Rack, Florian Schütz, & Elmar Stickeler. (2013). Breast Cancer News from ASCO 2013. Breast Care. 8(4). 307–309. 4 indexed citations
6.
Sleeman, Jonathan P., Jürgen Moll, Larry S. Sherman, et al.. (2007). The Role of CD44 Splice Variants in Human Metastatic Cancer. Novartis Foundation symposium. 189. 142–156. 4 indexed citations
7.
Stoff‐Khalili, Mariam A., Long P. Le, Alexander Stoff, et al.. (2006). Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents. Cancer Gene Therapy. 13(6). 606–618. 21 indexed citations
8.
Stoff‐Khalili, Mariam A., Peter Dall, & David T. Curiel. (2006). Gene therapy for carcinoma of the breast. Cancer Gene Therapy. 13(7). 633–647. 31 indexed citations
9.
Stoff‐Khalili, Mariam A., Alexander Stoff, Ángel A. Rivera, et al.. (2005). Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system. Breast Cancer Research. 7(6). R1141–52. 29 indexed citations
10.
Stoff‐Khalili, Mariam A., Alexander Stoff, Ángel A. Rivera, et al.. (2005). Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. Cancer Biology & Therapy. 4(11). 1203–1210. 27 indexed citations
11.
Dufault, Michael R., Beate Betz, Barbara Wappenschmidt, et al.. (2004). Limited relevance of the CHEK2 gene in hereditary breast cancer. International Journal of Cancer. 110(3). 320–325. 70 indexed citations
12.
Betz, Beate, Andrea R. Florl, Hans‐Helge Seifert, et al.. (2004). Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer. Human Mutation. 23(6). 612–620. 14 indexed citations
13.
Azémar, Marc, S. Djahansouzi, Elke Jäger, et al.. (2003). Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2. Breast Cancer Research and Treatment. 82(3). 155–164. 69 indexed citations
14.
15.
Minckwitz, Gϋnter von, Serban Dan Costa, Peter Dall, et al.. (2002). Evidence-Based Recommendations on Treating Locoregional and Distant Metastases of Carcinomas of the Breast. Zentralblatt für Gynäkologie. 124(5). 284–292. 4 indexed citations
16.
Fieber, Christina, et al.. (1999). Characterisation of the murine gene encoding the intracellular hyaluronan receptor IHABP (RHAMM). Gene. 226(1). 41–50. 34 indexed citations
17.
Dall, Peter, Jan G.M. Klijn, Maxime P. Look, et al.. (1999). Prognostic value of CD44 variant expression in primary breast cancer. International Journal of Cancer. 84(3). 209–215. 48 indexed citations
18.
Dall, Peter, Armin Hekele, Hans Ikenberg, et al.. (1996). Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. International Journal of Cancer. 69(2). 79–85. 29 indexed citations
19.
Grote, J., Peter Dall, Kerstin M. Oltmanns, & W. Stolp. (1994). The Effect of Increased Blood Carbon Monoxide Levels on the Hemoglobin Oxygen Affinity During Pregnancy. Advances in experimental medicine and biology. 345. 145–150. 5 indexed citations
20.
Bois, Andreas du, H. G. Meerpohl, H. Madjar, et al.. (1994). Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer. Journal of Cancer Research and Clinical Oncology. 120(3). 173–178. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriyuki Takai Breakdown of academic impact, for papers by Lorraine Robb Breakdown of academic impact, for papers by Luc Bélanger Breakdown of academic impact, for papers by Riccardo Giannini Breakdown of academic impact, for papers by R Swain Breakdown of academic impact, for papers by Jun Yamamoto Breakdown of academic impact, for papers by Rainer Lehtonen Breakdown of academic impact, for papers by Daniel Auclair Breakdown of academic impact, for papers by Mercedes Herrera Breakdown of academic impact, for papers by Donald R. Howard
Rankless by CCL
2026